The 2023 data highlights that Russia, Slovakia, Bulgaria, and Romania achieved perfect international collaboration in scientific publications on complementary and manual therapy. Norway and Malaysia also demonstrated substantial collaboration with over 80% involvement. In contrast, major research nations like the United States and Japan ranked lower, with less than 10% participation, reflecting a stronger domestic focus or alternate collaboration networks. No significant year-on-year variation was reported, indicating stability rather than growth or decline.
Future trends to monitor include increasing global connectivity, which may elevate collaboration percentages, particularly in countries with currently low engagement. As complementary and manual therapies gain global interest, expect more countries to push for international research partnerships.
Top countries in Share of Scientific Publications Involving International Collaboration in Complementary and Manual Therapy by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Russia | 100 | 2021 | View data |
| 2 | 2 Slovakia | 100 | 2021 | View data |
| 3 | 3 Bulgaria | 100 | 2021 | View data |
| 4 | 4 Romania | 100 | 2021 | View data |
| 5 | 5 Norway | 96.17 | 2023 | View data |
| 6 | 6 Malaysia | 84.28 | 2023 | View data |
| 7 | 7 Finland | 83.22 | 2023 | View data |
| 8 | 8 Cyprus | 77.88 | 2021 | View data |
| 9 | 9 Netherlands | 74.44 | 2023 | View data |
| 10 | 10 New Zealand | 59.85 | 2023 | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...